^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Small Intestinal Carcinoma
    Drug:capecitabine (Thymidylate synthase inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Small Bowel Adenocarcinoma: Adjuvant therapy regimens…Capecitabine